Martina Navratilova announces that she is in remission from her two cancers

Martina Navratilova announces that she is in remission from her

  • News
  • Published on
    Updated


    Reading 2 mins.

    The former tennis champion did not hide her relief and announces it with joy to all her fans: she is officially in remission from her cancers. Indeed, Martina Navratilova, aged 66, had to face three cancers in her life: a first breast cancer in 2010 and a second in 2023 associated with throat cancer.

    Last January, Martina Navratilova, former world No. 1 in tennis, holder of 59 Grand Slam titles, explained that after having fought breast cancer in 2010, she was again affected by the disease, in the breast but also in throat, two stage 1 cancers.

    An announcement on Twitter for all his fans

    After several months of treatment, the former tennis star therefore shared his joy on social networks, officially announcing his remission. “After a full day of testing, everything is fine! Thank you to all the doctors, nurses, proton magicians, etc. What a relief !” she tweeted Monday, June 19, adding two hashtags “Bye-bye cancer” and “Fuck cancer”.

    What causes throat cancer?

    This type of cancer can be caused by the human papillomavirus, a virus responsible for cancers of the cervix but which can also affect the ENT sphere. It is spread through skin-to-skin contact, usually by having oral, vaginal, or anal sex with an infected person. Many people with HPV don’t realize they have it because there may be no signs or symptoms.

    The vaccine, recommended for adolescent girls and boys

    In the context of an oral HPV infection, it is in fact a sexually transmitted infection and it is also the most common. Symptoms of throat cancer include a sore throat, sometimes earache, difficulty swallowing, weight loss, and a lump or lump in the neck. Treatments include chemotherapy and radiotherapy sessions.

    Fortunately, throat cancer due to HPV has a good prognosis for treatment. For the youngest, the vaccine against the papillomavirus is recommended, both for young girls and young boys.




    dts1